Submit Buy Request
View Synopsis & Table of contentThe Transarterial Radioembolization (TARE) market is booming, projected to reach $3 billion by 2033, driven by rising liver cancer rates and technological advancements. Explore market trends, key players (Sirtex, Merit Medical, Boston Scientific), and regional growth in this in-depth analysis.
Total Amount: $6960.00
Our Clients
We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.
Key Highlights of Report
Mar, 2025
85
Tables
Base Year: 2024.
Coverage: 18 Countries
Companies: 15+
Connect With us
